First, most preclinical ALS studies invariably employ the mSOD1 transgenic rodents (generally SOD1G93A mice), which is a limited disease condition related to a small subgroup of ALS patients with SOD1 gene mutation. Here, SOD1 is linked to amyotrophic lateral sclerosis.